SCHEMBL3501690

SCHEMBL3501690

NCCC1CCC(C(=O)O)CC1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.68
PLG P00747 1/20 0.68
PLAT P00750 1/20 0.68
ANPEP P15144 2/20 0.48
ENPEP Q07075 1/20 0.48
GABRP O00591 1/20 0.39
GABRD O14764 1/20 0.39
GABRA1 P14867 1/20 0.39
TSHR P16473 1/20 0.39
GABRB1 P18505 1/20 0.39
GABRG2 P18507 1/20 0.39
GABRB3 P28472 1/20 0.39
GABRA5 P31644 1/20 0.39
GABRA3 P34903 1/20 0.39
GABRA2 P47869 1/20 0.39
GABRB2 P47870 1/20 0.39
GABRA4 P48169 1/20 0.39
GABRE P78334 1/20 0.39
PMP22 Q01453 1/20 0.39
GABRA6 Q16445 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9505558 1.00 LMNA (0.68) LMNAPLGPLATANPEPENPEP
SCHEMBL3501688 1.00 LMNA (0.68) LMNAPLGPLATANPEPENPEP
Hydrochloric Acid SCHEMBL7328494 0.98 LMNA (0.65) LMNAPLGPLATANPEPENPEP
SCHEMBL9294046 0.92 LMNA (0.59) LMNAPLGPLATANPEPENPEP
SCHEMBL9506256 0.87 PLG (0.57) LMNAPLGPLATANPEPENPEP
SCHEMBL11664391 0.85 LMNA (0.65) LMNAPLGPLATANPEPENPEP
SCHEMBL850864 0.84 LMNA (0.64) LMNAPLGPLATANPEPENPEP
SCHEMBL9293095 0.84 LMNA (0.59) LMNAPLGPLATANPEPENPEP
SCHEMBL8897842 0.82 LMNA (0.45) LMNAPLGPLATANPEPENPEP
Tranexamic Acid SCHEMBL186034 0.81 PLG (1.00) LMNAPLGPLATANPEPENPEP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0366285-B1 Method for production of human tissue type plasminogen activator MITSUI TOATSU CHEMICALS (JP) 1994-12-28 EP claimed
EP-0329105-B1 MOLECULAR WEIGHT CONTROLLER FOR POLYMERIZATION OF LACTAMS TO POLYAMIDES BASF Corporation (US) 1993-07-07 EP claimed
US-5183754-A Activating cells under increased osmotic pressure provided by bicarbonate ions MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1993-02-02 US claimed
US-5006635-A Monofunctional amine, monofunctional acid, salt of aminoacid, polyamides BASF CORPORATION (US) 1991-04-09 US claimed
EP-0366285-A1 Method for production of human tissue type plasminogen activator MITSUI TOATSU CHEMICALS, Inc. (JP) 1990-05-02 EP claimed
EP-0329105-A2 Molecular weight controller for polymerization of lactams to polyamides BASF Corporation (US) 1989-08-23 EP claimed
JP-62004233-A None JP disclosed
US-12624161-B2 Water dispersible polymer for use in additive manufacturing STRATASYS, INC. (US) 2026-05-12 US disclosed
EP-3310843-B1 WATER DISPERSIBLE POLYMER FOR USE IN ADDITIVE MANUFACTURING STRATASYS INC (US) 2024-09-18 EP disclosed
EP-3700595-B1 KITS FOR ANCHORING IMPLANTABLE MEDICAL DEVICES MEDTRONIC INC (US) 2024-06-19 EP disclosed
US-11952612-B2 Protease sensor molecules COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2024-04-09 US disclosed
EP-3538665-B1 PROTEASE SENSOR MOLECULES PPB TECH PTY LTD (AU) 2024-01-03 EP disclosed
US-20230265240-A1 WATER DISPERSIBLE POLYMER FOR USE IN ADDITIVE MANUFACTURING STRATASYS INC (US) 2023-08-24 US disclosed
US-4844834-A Molecular weight controller for polymerization of lactams to polyamides BASF CORPORATION (US) 1989-07-04 US disclosed
US-4719203-A CALCIUM METABOLISM DISORDERS BOEHRINGER MANNHEIM GMBH (DE) 1988-01-12 US disclosed
EP-0224751-A1 Diphosphonic-acid derivatives, process for preparing them and medicines containing these compounds Roche Diagnostics GmbH (DE) 1987-06-10 EP disclosed
EP-0208486-A2 Process for producing tissue plasminogen activator Toyo Boseki Kabushiki Kaisha (JP) 1987-01-14 EP disclosed
JP-S624233-A PRODUCTION OF HISTOGENOUS PLASMINOGEN ACTIVATOR TOYOBO CO LTD 1987-01-10 JP disclosed
US-3996201-A MOLDING CIBA-GEIGY CORPORATION (US) 1976-12-07 US disclosed
US-3988333-A Tri-substituted aluminum salts or di-substituted aluminum salts of carboxyl group-containing, pharmaceutically effective compounds TEIKOKU HORMONE MFG. CO., LTD. (JA) 1976-10-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12624161-B2 Water dispersible polymer for use in additive manufacturing SMC3, SMCHD1, SMC4 LMNA 1968/4885PLG 522/4885PLAT 671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.